SureTrader Stock Hero Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator biovalidator, KingDMC
Search This Board:
Last Post: 5/19/2015 9:32:34 PM - Followers: 388 - Board type: Free - Posts Today: 0

Logo: Inovio

ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE-

Float: 97.65 M

Shares Outstanding: 127.26 M

Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.

Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
INO News: Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers 12/18/2014 06:00:00 AM
INO News: Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology 12/17/2014 08:00:00 AM
INO News: Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 12/15/2014 08:00:00 AM
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#12964   Inovio Pharmaceuticals Rating Increased to Buy at Zacks (INO) nanopatent 05/19/15 09:32:34 PM
#12963   What is up with the little run up justdothis 05/19/15 04:23:05 PM
#12962   Sertant acquired Star Biologics, Inc. in April of Roscoe85 05/16/15 12:19:14 PM
#12961   Star Biologics nanopatent 05/14/15 05:15:37 PM
#12960   Chen, Yin + ssDNA nanopatent 05/14/15 05:10:55 PM
#12959   True But who? nanopatent 05/14/15 04:53:13 PM
#12958   Acknowledged, I saw that sometime ago but someone Roscoe85 05/14/15 02:07:03 PM
#12957   Re CytoGenix: nanopatent 05/13/15 08:41:01 PM
#12956   Here is some homework for you. No plasmids Roscoe85 05/13/15 05:50:32 PM
#12955   Something as revolutionary to medicine as electroporation and nanopatent 05/12/15 08:40:13 PM
#12954   Invio wil go to $15.00 by the end Hardthought 05/12/15 04:27:25 PM
#12953   nut instead of a brain. do your homework 957Df 05/12/15 03:08:36 PM
#12952   Better profile stability at room temperature compared to 957Df 05/12/15 03:04:04 PM
#12951   I see no problem with electroporation - simple, nanopatent 05/12/15 03:01:24 PM
#12950   This company is on the right track imo Roscoe85 05/12/15 02:42:45 PM
#12949   When these Inovio guys get their shit together nanopatent 05/12/15 01:16:57 PM
#12948   They will never make it. Still using plasmids, Roscoe85 05/12/15 12:46:55 PM
#12947   They'll never make it with their delivery method. Roscoe85 05/12/15 12:31:42 PM
#12945   Needs to cut out all the clinical trial KingDMC 05/12/15 09:16:13 AM
#12944   Ebola... Ya ok. Bunk 05/12/15 06:59:42 AM
#12943   Inovio Initiates Clinical Trial With DNA Immunotherapies to KingDMC 05/12/15 06:06:24 AM
#12942   There is much truth to what you say. Everywhereman 05/11/15 03:29:17 PM
#12941   Ha! In both for for Long Term. Management Imaginaryharry 05/11/15 01:33:31 PM
#12940   While I clearly agree that cash is king, ppnlf 05/11/15 01:07:03 PM
#12939   I was not a fan of the rs, Everywhereman 05/11/15 12:30:32 PM
#12938   Oncs baby! That's where it's at. Bunk 05/11/15 11:45:41 AM
#12937   I just don't see why closing the share ppnlf 05/06/15 10:19:55 AM
#12936   Fwiw I just got in this as a pfc0789 05/01/15 07:40:02 PM
#12935   FWIW - I've been in this at $1.10, nanopatent 04/30/15 05:48:24 PM
#12934   Good. nanopatent 04/30/15 05:45:13 PM
#12933   Doesnt matter, this future not 50 pps next harry crumb 04/30/15 04:12:45 PM
#12932   Im not dreaming at all, 600$ nah, 50-60 harry crumb 04/30/15 04:09:06 PM
#12931   But I am dreaming like those who believe kpisme 04/30/15 03:25:38 PM
#12930   Should be and would be if market confidence ppnlf 04/30/15 02:46:32 PM
#12929   Would not the $76 million from this underwriting nanopatent 04/30/15 02:39:00 PM
#12928   And when we break support at $8 we ppnlf 04/30/15 02:34:51 PM
#12927   A look at the brighter side.... For INO CCruzNY 04/30/15 01:39:31 PM
#12926   Be reasonable - GOOG is ~ $600. nanopatent 04/30/15 01:39:29 PM
#12925   I guess the only consolation in today's sorry ppnlf 04/30/15 01:28:47 PM
#12924   Why stop there with the dreaming A million kpisme 04/30/15 12:31:12 PM
#12923   $20? This INO is the Google of biotech. nanopatent 04/30/15 10:13:52 AM
#12922   Agree, thinking its Ebola trial or a P3 Tate 04/30/15 09:49:01 AM
#12921   I'm a big believer in DR Kim since KingDMC 04/30/15 09:46:23 AM
#12920   Yeah, whatever! kpisme 04/30/15 09:40:24 AM
#12919   Seen that now. Given the market cap of ppnlf 04/30/15 09:28:44 AM
#12918   Because they are raising $76M! Great things happening Tate 04/30/15 09:20:51 AM
#12917   Why is the PM price drop so large? ppnlf 04/30/15 09:14:09 AM
#12916   What a golden oppertunity to add! People, use harry crumb 04/29/15 04:57:58 PM
#12915   Inovio Initiates Equity offering... CCruzNY 04/29/15 04:32:52 PM
#12914   Here is another abstract in for May biovalidator 04/28/15 11:13:45 AM